Advertisement
Advertisement
Keytruda

Keytruda

Basic Prescribing Info
Contents
Pembrolizumab
MIMS Class
Targeted Cancer Therapy / Cancer Immunotherapy
ATC Classification
L01FF02 - pembrolizumab ; Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement